Boulder, CO, United States of America

Gulsu Sener Yildirim

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gulsu Sener Yildirim. Retrieved from https://idiyas.com/inventor/gulsu-sener-yildirim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gulsu Sener Yildirim: Innovator in Zwitterionic Hydrogels

Introduction

Gulsu Sener Yildirim is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of bioactive materials, particularly through his innovative work with zwitterionic hydrogels. His research focuses on enhancing the delivery of therapeutic agents, which has important implications for medical treatments.

Latest Patents

Gulsu Sener Yildirim holds a patent for the "Sustained release of bioactive factors from zwitterionic hydrogels." This patent describes methods for producing microporous zwitterionic cryogels that are effective in sustaining the release of therapeutic agents. The cryogels developed by Yildirim address several limitations of existing compositions, showcasing high loading efficiencies and a sustained release profile with minimal burst for up to four months or more. The characteristics of these cryogels can be tailored by altering the selection of monomers and crosslinkers, allowing for precise control over the cryogel's chemistry.

Career Highlights

Throughout his career, Gulsu Sener Yildirim has demonstrated a commitment to advancing the field of biomedical materials. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Gulsu has collaborated with Melissa D Krebs, who is also a prominent figure in the field. Their partnership has contributed to the development of cutting-edge technologies in bioactive materials.

Conclusion

Gulsu Sener Yildirim's work in zwitterionic hydrogels represents a significant advancement in the field of therapeutic delivery systems. His innovative patent and collaborative efforts highlight his dedication to improving medical treatments through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…